Chronic Suppurative Otitis Media

Chronic suppurative otitis media is one of the most common causes of preventable hearing loss in the world — the WHO estimates 65–330 million people are affected, predominantly in low- and middle-income countries. In a busy ENT outpatient department in India or Africa, CSOM is the most frequent diagnosis. But the term covers two fundamentally different disease processes, and conflating them is one of the most consequential errors in ENT clinical practice. The distinction between tubotympanic (safe) and atticoantral (unsafe, dangerous) disease must be made in every patient with chronic ear discharge.

---

What Makes CSOM “Chronic”?

By convention, otitis media becomes chronic when there is:

• Persistent perforation of the tympanic membrane
• Discharge (otorrhoea) lasting more than 2–3 months
• Evidence of ongoing middle ear mucosal or bony disease

This distinguishes CSOM from acute suppurative otitis media (ASOM), which lasts days to weeks and typically resolves with or without antibiotics, and from otitis media with effusion (OME/glue ear), which involves an intact tympanic membrane.

---

The Two Types — An Overview

The safe/unsafe classification describes both the anatomical location of disease and its clinical danger:

Feature	Tubotympanic (Safe)	Atticoantral (Unsafe)
Perforation site	Central — pars tensa	Marginal or attic — posterosuperior or pars flaccida
Disease location	Mesotympanum (middle portion)	Epitympanum (attic), antrum, mastoid
Discharge	Mucopurulent, intermittent, odourless	Foul-smelling, persistent, offensive
Cholesteatoma	Absent	Present (by definition or by high risk)
Bone erosion	Absent	Present
Complications	Uncommon	Common
Urgency	Elective management	Urgent surgical referral

---

Tubotympanic (Safe) CSOM

Pathology

The disease is confined to the mesotympanum — the middle portion of the tympanic cavity, bounded above by the drum (pars tensa level). The mucosa lining the middle ear is chronically inflamed, producing mucopurulent secretions. The perforation is central — it involves the pars tensa but has a rim of residual drum around it at the annulus. This is the anatomical definition of a central (safe) perforation. The annulus acts as a barrier preventing squamous epithelium from migrating into the middle ear.

There is no bone erosion, no cholesteatoma. The ossicular chain is typically intact, though the long process of the incus may erode with severe or long-standing disease.

Clinical Features

• Intermittent, painless otorrhoea — mucopurulent, odourless (or mildly musty), often occurring with upper respiratory infections that exacerbate the middle ear mucositis via the Eustachian tube
• Hearing loss — conductive, typically 20–40 dB, corresponding to the size of the perforation and any ossicular involvement
• Dry interval — in many patients, the ear is dry between infectious episodes. This distinguishes tubotympanic CSOM from atticoantral disease, where discharge is often persistent
• No pain — pain in CSOM suggests a complication (masked mastoiditis, coalescent mastoiditis) or an incorrect diagnosis

Audiological Correlation

Perforation size correlates roughly with the degree of conductive hearing loss:

• Small (<25% drum area): ~10–25 dB loss
• Moderate (25–50%): ~25–35 dB
• Large (>50%): ~35–45 dB
• Subtotal (near-total): up to ~45–50 dB

Disruption of the ossicular chain increases the air-bone gap to 55–60 dB and is suggested by a hearing loss disproportionate to the perforation size.

---

Atticoantral (Unsafe) CSOM

Pathology

The disease involves the epitympanum (attic), aditus ad antrum, and often the mastoid. The hallmark is cholesteatoma — keratinising squamous epithelium that has gained access to the middle ear either through a marginal perforation or via a self-retaining retraction pocket of the pars flaccida. For a full account of cholesteatoma pathology, see the cholesteatoma article.

The key concept: atticoantral disease is dangerous because of what it can destroy — the ossicular chain, the bony labyrinthine capsule, the facial nerve canal, and the tegmen. These complications are not rare complications of severe disease; they are the natural history of untreated atticoantral CSOM.

Clinical Features

• Persistent, foul-smelling otorrhoea — the offensive smell is characteristic and diagnostic. The keratin mass of the cholesteatoma becomes infected with gram-negative organisms (primarily Pseudomonas aeruginosa and Proteus), producing a distinctive fetid odour. If a patient’s ear discharge smells bad and does not clear with topical antibiotics, the diagnosis is cholesteatoma until proven otherwise.
• Attic crust or retraction — visible on otoscopy as scaly debris or a keratin-filled retraction pocket in the pars flaccida (attic area, above the short process of the malleus)
• Marginal perforation — a perforation involving the posterosuperior quadrant or the drum margin (annulus), rather than the safe central area
• Conductive hearing loss — often greater than expected from the perforation size alone, because ossicular erosion is common
• Complications if advanced — facial nerve palsy, vertigo (labyrinthine fistula), or signs of intracranial involvement

Why “Unsafe”?

The term “unsafe” is a clinical warning that the disease has the potential for serious, life-threatening complications. The pathway from atticoantral CSOM to meningitis, brain abscess, or facial nerve paralysis is well-established:

1. Cholesteatoma erodes the tegmen → extradural abscess → meningitis/brain abscess
2. Cholesteatoma erodes the facial nerve canal (tympanic segment) → facial nerve palsy
3. Cholesteatoma erodes the labyrinthine capsule (lateral SCC) → labyrinthine fistula → SNHL, vertigo
4. Cholesteatoma erodes the sigmoid sinus plate → sigmoid sinus thrombophlebitis → septicaemia

These are not rare, historical complications — they continue to present in every ENT department that serves populations with limited access to early intervention.

---

Investigations

Otoscopy under microscope (aural microscopy): The gold standard for assessment. Wax and discharge are cleared; the entire drum and attic are examined systematically. Cannot be replaced by standard otoscopy alone for atticoantral disease.

Audiogram: Quantifies the conductive hearing loss and detects any sensorineural component (indicating cochlear damage from toxins, labyrinthine fistula, or direct cochlear involvement).

CT temporal bones (HRCT): Essential in atticoantral disease to define the extent of cholesteatoma, assess ossicular erosion, proximity to the facial nerve canal, and tegmen integrity. Not routinely required for straightforward tubotympanic CSOM without complications.

MRI (DWI): For suspected recurrent or residual cholesteatoma after surgery (see cholesteatoma article).

Swab for culture and sensitivity: In active discharge to guide antibiotic therapy — Pseudomonas aeruginosa is the most common isolate.

---

Complications of CSOM

The Palva classification divides complications into extracranial and intracranial:

Extracranial:

• Acute mastoiditis (subperiosteal abscess, Bezold’s abscess, Luc’s abscess)
• Labyrinthine fistula (lateral SCC most common)
• Petrositis (Gradenigo’s syndrome: deep ear pain, diplopia from CN VI palsy, ipsilateral discharge — the triad)
• Facial nerve palsy

Intracranial:

• Meningitis
• Extradural abscess
• Subdural abscess
• Brain abscess (temporal lobe most common)
• Sigmoid sinus thrombophlebitis
• Otitic hydrocephalus

Any patient with CSOM presenting with headache, neck stiffness, fever, facial nerve palsy, vertigo, or neurological signs has an intracranial or extracranial complication until proven otherwise.

---

Key Numbers

Parameter	Value
WHO global CSOM estimate	65–330 million affected
Definition: duration	Otorrhoea >2–3 months + TM perforation
Tubotympanic: perforation site	Central (pars tensa, margin intact)
Atticoantral: perforation site	Marginal or attic
Most common causative organism	Pseudomonas aeruginosa
Small perforation conductive loss	~10–25 dB
Ossicular disruption conductive loss	~55–60 dB
Most dangerous complication	Meningitis, brain abscess
Gradenigo’s syndrome triad	Otalgia + diplopia (CN VI) + ipsilateral discharge

---

Frequently Asked Questions

How do you tell the difference between safe and unsafe CSOM at the bedside? The two most reliable clinical clues are the smell and the location of the perforation. Foul-smelling discharge + posterosuperior or attic crust = atticoantral/unsafe until proven otherwise. Odourless mucopurulent discharge + central drum perforation = tubotympanic/safe. These are not perfect rules — early atticoantral disease may have minimal discharge, and some tubotympanic ears get secondarily infected with Pseudomonas producing an odour — but in practice, the combination is highly discriminating. Any uncertainty requires microscopic examination and CT.

Can CSOM be treated with antibiotics alone? Tubotympanic CSOM active episodes respond to topical antibiotic-steroid drops (microsuction first to clear debris, then drops) — this is appropriate initial management. The underlying perforation, however, does not close with antibiotics alone; definitive management is tympanoplasty (myringoplasty) when the ear is dry and the hearing is to be improved. Atticoantral CSOM cannot be treated medically — surgery is mandatory, because no antibiotic can eradicate cholesteatoma.

What is the difference between CSOM and ASOM? ASOM is acute, painful, and involves an intact (or newly perforated) tympanic membrane with a short disease course (days to weeks). The child with fever, otalgia, and a bulging red drum has ASOM. CSOM is chronic (>2–3 months), typically painless (pain = complication), and always involves a pre-existing perforation. The pathology and management are entirely different.